Skip to main content
ByMarch 11, 2026~24 min read

Yozmot 2025: There Is Pipeline, There Are Bonds, But Cash Still Needs Proof

Yozmot ended 2025 with a balance sheet that expanded to NIS 362.9 million, two public bond series, and a wider development stack. But operating cash flow remained negative, reported equity was still only NIS 30.3 million, and a meaningful part of the step-up still sits in permits, Tshuva-related transactions, and 80-20 sales rather than in accessible cash.

CompanyYozmot

Getting To Know The Company

At first glance, Yozmot looks like a fast-expanding urban-renewal platform. It operates in Israeli residential renewal, is advancing about 50 projects in central Israel, talks about roughly 4,000 new housing units of which 2,758 are for sale, and holds both an execution arm and a marketing arm inside the group. In 2025 it also became, in practical terms, a public bond issuer with two listed series, so on the surface it looks like a platform that has already stepped up.

But that is only half the story. The balance sheet stepped up faster than the cash flow. The company ended the year with NIS 362.9 million of assets versus NIS 100.1 million a year earlier, yet operating cash flow was still negative at NIS 35.1 million, and reported equity stood at only NIS 30.3 million. In other words, Yozmot is no longer a tiny developer looking for a foothold, but it is also not yet a seasoned execution story that funds its growth out of collections and released surpluses.

What is working now? Revenue rose to NIS 28.45 million in 2025, gross profit rose to NIS 5.7 million, the operating loss narrowed to NIS 3.4 million, and seven projects received building permits. Yozmot Engineering, the group’s construction arm, says it expects to be able to execute roughly 10 projects in parallel during 2026, and the company continues to operate through a relatively integrated model that combines origination, execution, and marketing inside one group.

What is the problem? The accounting numbers are already running ahead of cash. Trade receivables and accrued revenue rose to NIS 13.6 million, while contract liabilities stood at only NIS 2.0 million. About 50% of the signed purchase agreements in force at the report date included 80-20 contractor-loan structures. At the same time, a meaningful part of the covenant cushion looks comfortable only because it is measured on adjusted equity that adds subordinated shareholder loans, not on reported equity.

There is also a practical screen constraint worth flagging early. Yozmot is listed as a bond-only company. There is no listed equity line giving investors a live market read, and there is no relevant short-interest layer. That means the near-term interpretation of 2026 will flow mainly through the credit lens: the pace of releasing Series B proceeds, covenant headroom, the pace of moving into execution, and the conversion of permits and agreements into actual collections.

The Economic Map In One View

LayerStatus at end-2025Why it matters
Core activityAbout 50 projects, roughly 4,000 new housing units, mainly urban renewal in central IsraelThe pipeline is wide, but only a small portion already generates revenue and cash
Execution and marketing layerYozmot Engineering and Grakhan, 25 employees across the group, stated capacity for about 10 parallel projects in 2026The advantage is chain control, the risk is execution and financing bottlenecks
Financing layerSeries A bonds of NIS 49.5 million and Series B bonds of NIS 78.6 million parPublic funding opened options, but part of the money was still sitting in trust at year-end
Tshuva layerOsi 5-7 was acquired and recognized, a separate Y.T. Urban Renewal deal was signed but not recognized, and a broader MOU still existsThis is optionality, but not all of that optionality has become either an asset or cash
Public-market screenBond-only listing, no short-interest dataAnyone reading Yozmot should think first like a credit reader and only then like a pipeline reader

Strengths And Risks That Are Already Visible

TypeScoreWhy it matters
Strength: chain control4 / 5The company combines origination, execution, and marketing under one group instead of relying only on third parties
Strength: broad pipeline in demand areas3.5 / 5The projects are spread across central-demand cities, reducing dependence on one asset
Strength: new access to public debt3.5 / 5The two bond series opened a funding layer the company did not have in 2024
Risk: thin reported equity4 / 5Reported equity rose to only NIS 30.3 million, far below the comfort implied by adjusted equity
Risk: quality of growth4 / 580-20 sales and revenue recognized ahead of collections create a gap between accounting profit and cash
Risk: expansion through complex transactions4 / 5Tshuva-related transactions add pipeline, but also litigation, financing, partners, and meaningful fee layers

Events And Triggers

The Bond Issuances Bought Time, But They Did Not Solve The Execution Test

The most important event for Yozmot in 2025 was opening up public debt funding. In March, the company issued Series A for gross proceeds of NIS 49.52 million. In December, it issued Series B for gross proceeds of about NIS 78.61 million. That is a big move for a company of this size because it changes the funding mix, moving part of the financing base from private capital and related parties into the public market, and gives it more capacity to start several projects in parallel.

But the other side matters too. At end-2025, the full NIS 78.1 million of Series B proceeds was still sitting in trust. In other words, the financing line improved on paper faster than it improved the operating cash position. Only after the balance-sheet date did releases begin: on January 11, 2026 about NIS 4.3 million was released for Kaplinsky 20, on February 3, 2026 about NIS 10.0 million was released for Osi 11, and during March 2026 another roughly NIS 5.0 million was released for Margolin 31. That shows the money is starting to move, but it moves against project milestones and conditions, not all at once.

Osi 5-7 Created Accounting Value Immediately, But Cash Will Come Later

The most interesting transaction inside the Tshuva layer is Osi 5-7 in Netanya. This is an urban-renewal project involving a 29-floor tower with retail and offices and 94 housing units in total, of which 35 are for existing rights holders. The company holds an effective 51% interest in the project, but its profit share is 50%. That looks like a small detail, but it matters because it reminds readers that control percentage and economic share are not identical.

The surprising number here is not only the project itself, but the way it entered the accounts. Osi was classified as a business combination, and the company recorded NIS 7.0 million of other income from a bargain purchase. Behind that line sits a project to which the company attributes expected gross profit of NIS 84.4 million and expected distributable surplus of NIS 85.1 million under its end-2025 assumptions. That sounds strong, but the still-open pieces matter. Construction is scheduled to begin only in the fourth quarter of 2026, and another NIS 19.1 million of equity still had to be invested in the project at the reporting date.

So Yozmot booked the accounting value earlier than the cash value. That does not make the project weak. If anything, it suggests the company bought into an attractive asset. But it does mean that part of the 2025 improvement sits in discounted project value rather than in cash already moving upstream.

The Broader Tshuva Layer Is Still Not A Balance-Sheet Fact

In October 2025 the company also signed a separate deal for 51% of a joint company that holds 50% of Y.T. Urban Renewal in Netanya, which in turn holds five urban-renewal projects. That sounds like a natural widening of the pipeline. But in December 2025, a declaratory lawsuit was filed by Naor Cohen Initiation and Real Estate claiming the share allocation had been executed unlawfully. The company says it has strong arguments, but in the annual report it explicitly states that it cannot conclude that the probability of dismissal is higher than 50%, and therefore did not include the investment in the financial statements.

That is a material finding. Signing a transaction is not the same as having a recognized asset. Anyone reading Yozmot as if this whole layer is already in the base case is getting ahead of the company’s own accounting stance. As long as the claim remains open, management itself is not willing to count the investment as part of the balance sheet.

The Broad Tshuva MOU Adds Optionality, But Not Cheap Optionality

In November 2025 the company also signed a broader memorandum of understanding with seven private companies controlled by Yitzhak Tshuva. It opens the door to 51% allocations in project companies, subject to due diligence, and also includes mutual first-refusal rights for future projects. That is a possible growth engine, but it is far from free. The MOU also sets management and entrepreneurial fees of NIS 50 million plus VAT to be paid over four years, as well as a right of first refusal for Tshuva’s construction company to execute the projects at market terms to be set in a zero report.

So this layer could widen Yozmot quickly, but it also brings in more cost, more negotiation, more partner dependence, and a higher risk that the optionality will look better in a slide than in cash flow.

| Layer | Status at end-2025 | What is already in the accounts | What is still open | |-----|------|-------| | Osi 5-7 | Acquired and effectively controlled | Bargain-purchase gain, project inventory, and project disclosure are already in the accounts | Additional equity, actual execution, and timing of surplus release | | Y.T. Urban Renewal | Signed transaction for 51% in a joint company with 5 projects | Not recognized in the accounts | Open litigation and lack of sufficient certainty | | Broad MOU | Option on 7 project companies | No recognized asset yet | Due diligence, shareholder agreements, management fees, and financing burden |

Efficiency, Profitability And Competition

The operating direction improved in 2025, but not yet enough to say the model has been fully proved. Revenue rose to NIS 28.45 million from NIS 11.16 million in 2024. Gross profit rose to NIS 5.70 million from NIS 3.34 million. The operating loss narrowed to NIS 3.43 million from NIS 7.74 million, and the net loss fell to NIS 6.43 million from NIS 9.58 million.

Revenue, gross profit, and net loss

The main driver was a shift from planning into execution and revenue recognition. The company itself says revenue increased mainly because of units sold in Vinik 36 and Hashuk 35, as well as the start of execution in Kaplinsky 21 and Horowitz 39. That matters because it means 2025 revenue already rests in part on active projects, not only on fees or secondary services.

But quality is the real test here. The growth in sales also rests on easier financing terms for buyers. At the reporting date, about 15 buyers had signed agreements that include contractor loans, representing about 50% of the signed purchase agreements. The structure is 80-20: the buyer pays only around 20% upfront and the balance is paid at occupancy. The company explains that this helps stimulate demand, widens the buyer base, and may reduce drawdowns from project finance. That can all be true. But at the same time it delays collections, increases sensitivity to occupancy timing, and pushes the developer deeper into financing demand.

Revenue Is Running Faster Than Customer Cash

The gap between recognized revenue and customer cash is already visible in the accounts. Trade receivables and accrued revenue rose from NIS 2.27 million to NIS 13.55 million, while contract liabilities rose only from NIS 1.88 million to NIS 2.02 million.

Revenue recognition versus customer cash

That shows the company is recognizing revenue faster than it is collecting cash. In accounting terms this is natural in the sector, especially for projects recognized by percentage of completion. In economic terms it means the 2025 revenue line has not yet passed the liquidity test. A reader who looks only at the top line can miss that the customer has not yet paid most of the money.

Costs Did Not Disappear, They Changed Form

Another important point is that the operating loss narrowed not only because revenue rose, but against an expense base that is still high relative to scale. G&A rose to NIS 13.83 million from NIS 9.08 million, mainly because of the move from private company to public issuer, higher payroll and controlling-shareholder compensation, bonuses, external advisers, and office costs. Selling and marketing expense rose to NIS 1.39 million, in part because the company was pushing projects expected to receive building permits during 2026.

So Yozmot is clearly stepping into a new phase, but the transition phase is still expensive. The company is investing in headquarters, legal and financing infrastructure, marketing, and business development before full execution volume has reached the profit line.

The Real Competitive Advantage Exists, But It Is Also The Bottleneck

Yozmot does have a real advantage: it does not only source and sign projects, it also executes and markets them through the group. That matters in urban renewal, where control over pace, coordination, and subcontractor management often matters more than any slogan. Yozmot Engineering holds a G4 contractor classification, and the group estimates it can execute up to 10 projects in parallel in 2026.

But this is also exactly where the bottleneck sits. The company explicitly says its production capacity depends mainly on the amount of equity available and its ability to raise more equity, not only on engineering capability. In other words, the operating edge exists, but it does not free the company from the financing test. In a business like this, if you cannot fund several active sites in parallel, a wide pipeline will not translate cleanly into growth.

Cash Flow, Debt, And Capital Structure

The right way to read Yozmot is not by asking whether it has a working-capital deficit. The more important question is how much cash is actually left after real uses during the period. On an all-in cash flexibility basis, 2025 was an investment year funded externally.

How 2025 ended with NIS 41.2 million of cash

The numbers are straightforward. Operating activity consumed NIS 35.1 million, investing activity consumed another NIS 106.9 million, and only financing activity, mainly the two bond issues and an additional bank loan, generated NIS 177.1 million that allowed the company to end the year with NIS 41.2 million of cash and cash equivalents. That is not an immediate distress number, but it does say very clearly: the growth of 2025 was not funded from the business itself.

No Working-Capital Deficit Does Not Mean Free Cash

The company ended the year with NIS 219.9 million of current assets against NIS 109.3 million of current liabilities. So, formally, there was no working-capital deficit. But the composition matters more than the aggregate. Inside current assets sit NIS 78.1 million of Series B proceeds in trust, NIS 2.8 million of restricted cash and deposits, NIS 1.7 million of short-term deposits, and NIS 78.2 million of building inventory for sale. That is very far from a pile of free distributable cash.

Where the balance-sheet growth came from

The chart makes the core point visible. The balance sheet expanded mainly through inventory, permits, acquisition advances, and transaction-related assets, not through cash accumulation. Combined inventory, short and long term, rose to NIS 157.1 million. Advances and investments on account of acquisitions rose to NIS 30.1 million. That is a real layer of potential value, but it still needs time, capital, and execution before it becomes released surplus.

The Capital Structure Improved, But Not In A Clean Way

At end-2025, bank and other credit stood at NIS 75.8 million, related-party loans at NIS 45.7 million, and bonds at NIS 125.8 million. Against that, reported equity stood at only NIS 30.3 million.

The debt and equity stack at end-2025

This is where one of the most important findings in the filing sits. The bond covenants are not measured on reported equity alone, but on adjusted equity, which adds subordinated shareholder loans. According to the filing, adjusted equity stood at NIS 76.0 million at end-2025.

Reported equity versus adjusted equity

That gap is not a technical detail. It is the heart of the financial read. Yozmot looks more comfortable on covenants because controlling shareholders left a subordinated capital layer inside the company. In the case of BPO, the loan balance including interest and linkage stood at NIS 51.2 million at the report date, carries 5% interest, is subordinated to the bonds, and can be repaid only after the bonds are fully repaid and out of 80% of actual surplus received, excluding surplus already pledged to outstanding bond series.

That clearly improves protection for bondholders. But it is not the same thing as equity generated from profits and cash. So when reading Yozmot’s covenant cushion, it is important to remember that it rests partly on controlling-shareholder support rather than only on retained earnings.

Covenants Are Not Screaming Distress, But They Do Not Tell One Uniform Story

At the immediate-acceleration level, the company is in compliance with both bond series. In Series A, adjusted equity stands at NIS 76.0 million against a NIS 25 million floor, and adjusted-equity-to-balance-sheet stands at 20.95% against a 20% floor. In Series B, adjusted equity stands at the same NIS 76.0 million against a NIS 30 million floor, and adjusted-equity-to-balance-sheet net of cash stands at 23.63% against a 20% floor.

But there is a yellow flag here that should not be softened. In Series A, the 20.95% ratio is above the immediate-acceleration floor, yet below the 22.5% threshold that triggers the step-up mechanism in interest. In Series B, the 23.63% ratio is still above that 22.5% threshold. So the company is not close to default, but it is also not in the same comfort zone across all layers of debt. That difference matters especially in a company the market reads through bonds rather than equity.

Outlook

Before getting into the project list itself, four points need to be held together to understand 2026:

  1. This is a proof year, not a harvest year. The company itself says that over the coming year it plans to keep advancing projects still in planning and to start executing some of them in parallel.
  2. Osi 5-7 has already created accounting value, but not yet released surplus. Construction is planned to start in the fourth quarter of 2026, and more equity still needs to go in.
  3. Y.T. Urban Renewal is still not in the base. As long as the litigation remains open, the five-project layer cannot be counted as if it were already recognized.
  4. The release of Series B proceeds will be an early credibility test. If the money keeps being released against genuine execution milestones, the read will improve. If not, the market will ask why the public raise is still trapped.

2026 Should Be The Year The Company Moves From Building A Balance Sheet To Building Sites

The company says it expects to continue advancing projects and begin executing some of them during the coming year. Yozmot Engineering is expected to execute around 10 projects in parallel during 2026, with the flexibility to rely on subcontractors as needed. That sounds ambitious, but it is also exactly why 2026 is the real test. Moving from permits, zero reports, and pre-sales into active construction requires not just planning, but labor, funding, subcontractors, and project-finance drawdowns that actually work in sequence.

In other words, 2025 was the year Yozmot showed it can package projects. 2026 needs to be the year it proves it can open them, finance them, and collect cash from them.

Osi 5-7 Has To Shift From A Valuation Story To An Execution Story

Osi 5-7 is probably the most important single project for the near-term reading of Yozmot. It already came with excavation and shoring permits, pre-sales, and attractive forecast profitability. After the balance-sheet date, on January 12, 2026, the subsidiary holding the project signed a financing and project-accompaniment agreement with non-bank financiers for about NIS 100 million, at prime plus 0.78%, alongside guarantee lines for Sale Law guarantees and other project needs.

That is a very important step, because it moves the project from economic estimate to real financing structure. But the filing is equally explicit about the other side: the agreement includes conditions precedent for funding, including pre-sales, equity injection, and a structural-contract signature. So the story does not end with financing being signed. It ends only when the conditions precedent become actual construction.

80-20 Sales Will Have To Pass The Collection Test

The company presents contractor loans as a commercial tool that reduces project-finance drawdowns and supports demand. That may be true at the entry point of the sale. But 2026 will bring the less comfortable test: whether those sales remain high quality when the company moves closer to delivery, or whether the gap between recognized revenue and cash remains wide. In residential development, a sale done on 80-20 terms is not economically equivalent to a sale where most of the cash arrives early.

That is why one of the key questions for 2026 and 2027 is not only how many apartments will be sold, but on what terms they are sold and when the cash actually comes in. If receivables continue to grow faster than collections, the company will remain more dependent on external financing even when the headlines look good.

What Has To Happen Over The Next 2 To 4 Quarters

CheckpointWhy it matters
More Series B releasesThis is the fastest test of whether the public raise is turning into a real operating tool rather than mostly a trust balance
Starts on several projects in parallelThis is the test of Yozmot Engineering and the management layer’s real execution capacity
Conversion of 80-20 sales into collectionsThis is the test of sales quality and whether gross profit will actually turn into cash
Clarity around Tshuva-related transactionsThis is the test of whether the optionality layer enters the balance sheet or remains a half-open story

If all four of these move together, Yozmot can shift from “a balance sheet that expanded quickly” to “an execution-and-financing company with a clear path.” If one or two of them stall, the outcome will be another year in which the pipeline looks larger than the cash flow.

Risks

The risk in Yozmot is not one single issue but four interacting layers.

Financing Risk

The company operates in a capital-intensive industry. It depends on bank or non-bank project finance, equity injections, and a public debt market that remains willing to fund it. The filing itself stresses that tighter equity requirements or credit limits in the sector could hurt the ability to move projects into execution. In a company like Yozmot, this is a core risk, not a side note.

Sales-Quality Risk

The 80-20 mechanism can be an effective commercial tool, but it is also a quality risk. The company prepays interest for the agreed financing period, while the meaningful collection is pushed outward. If the housing market weakens, if delivery gets delayed, or if buyers face more expensive end-financing at the final payment stage, part of the economic quality of the sale can erode.

Planning And Execution Risk

The company operates in urban renewal, so every project depends on permits, long planning processes, holdout tenants, and a fragile execution chain. On top of that, the company itself writes about labor shortages in the sector, rising labor costs, and the effect of the security environment on foreign-worker availability. Anyone building a thesis around a surge in execution in 2026 has to remember that even if demand exists, execution can still be the bottleneck.

Two legal layers stand out in the filing. One is an older claim relating to a transaction that never completed, for which a provision has been recorded. The other, and the one that matters more for the thesis, is the claim against Y.T. Urban Renewal, which currently prevents the company from counting that investment in the accounts. Beyond the legal point, expansion through partner-led transactions also adds another layer of coordination, dilution mechanisms, and cases in which formal control does not necessarily guarantee full control over pace.

Conclusions

Yozmot is coming out of 2025 as a larger company, a better-funded company, and a company with a much wider project layer than it had a year earlier. That is the supportive side of the thesis. The main block is that the balance sheet has moved ahead of the cash flow: sales partly rely on 80-20 structures, reported equity remains thin, and an important layer of Tshuva-related optionality still sits either outside the balance sheet or before execution. In the near term, the company will be re-rated less on another “new deal” headline and more on the pace of Series B releases, actual construction starts, and the ability to show collections rather than only recognition.

Current thesis: Yozmot built a wider financial and project framework in 2025, but 2026 still has to prove that this framework can generate cash rather than only a larger balance sheet.

What changed: The company moved from a model funded mainly by private capital and related-party support into one that now involves public debt, multiple permits, and Tshuva-related transactions, so both the complexity and the market’s expectations have stepped up.

The strongest counter-thesis: It is entirely possible to argue that the balance sheet grew faster than the company’s ability to execute, that reported equity remains too thin, and that Yozmot will keep rolling its expansion through new debt and shareholder loans before it can show real released surplus.

What could change the market reading in the short-to-medium term: A sequence of Series B releases, additional project-finance agreements, and real starts on several projects would show that public debt has actually become a growth tool. On the other hand, another quarter in which receivables keep running faster than cash, or more stagnation in Tshuva-related transactions, would push the reading back toward credit-risk concerns.

Why this matters: Yozmot is no longer being tested only as a small pipeline developer. It is now being tested as a company that has to manage financing, execution, sales, and partnerships at the same time. The gap between accounting value and distributable cash will decide whether 2025 was a real foundation year or merely a year of re-packaging.

What must happen over the next 2 to 4 quarters for the thesis to strengthen, and what would weaken it: The thesis strengthens if Series B money keeps being released against real execution, if several projects move into construction, and if 80-20 sales convert into clean collections. It weakens if the company keeps adding inventory and receivables without matching cash flow, or if the Tshuva layer remains stuck between litigation, memorandum language, and financing needs.

MetricScoreWhy it matters
Overall moat strength3.5 / 5The relative control over origination, execution, and marketing is real, but it is not yet proved at large execution scale
Overall risk level4 / 5Thin reported equity, negative operating cash flow, and dependence on external funding keep risk elevated
Value-chain resilienceMediumOperating control is better than in many smaller developers, but financing, permits, and labor can still slow the whole chain
Strategic clarityMediumIt is clear the company wants to scale through urban renewal, but much of the new pipeline is still conditional or unrecognized
Short-interest positioningNo short-interest data availableThe company is listed as a bond-only issuer, so the near-term public reading comes through debt and covenant dynamics

Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.

The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.

The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.

Found an issue in this analysis?Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction
Follow-ups
Additional reads that extend the main thesis